The ladies’s well being marketplace is fraught with boundaries, from a loss of analysis and investment to regulatory pressures towards reproductive well being. But it surely’s gaining extra consideration as smartly, which may also be observed from the choice of girls’s well being startups coming into the marketplace. That’s why we’re launching MedCity FemFwd, a podcast devoted to inspecting the demanding situations and breakthroughs in girls’s well being.

Michelle Lengthy, senior coverage analyst for the Girls’s Well being Coverage program at KFF

Every month, MedCity Information Reporter Marissa Plescia will take a seat down with leaders within the house to talk about well timed girls’s well being subjects, together with sexual well being, fertility, being pregnant, menopause and center well being. You probably have any ideas for episodes, you’ll e mail mplescia@medcitynews.com.

Within the inaugural episode, Michelle Lengthy, senior coverage analyst for the Girls’s Well being Coverage program at KFF, talks about Opill, which just lately made headlines as the primary day by day oral contraceptive licensed for nonprescription use within the U.S. Lengthy tells listeners why this information is very important and examines whether or not the medicine shall be coated via insurance coverage.